Do opioids effectively control moderate-to-severe cancer pain? A recent review of the evidence says yes, though the press release for the study says otherwise, its headline declaring that the efficacy of opioids against cancer pain remains "unclear." Both statements can't be true, so which one is false?
Join Cameron English and Dr. Chuck Dinerstein as they examine a case of opioid research with "a side of corruption" on Episode 62 of the Science Dispatch podcast:
More than a third of patients with cancer report experiencing "moderate-to-severe cancer-related pain;” 40% of these patients experience “breakthrough pain” on their pain regimens. Opioid analgesics remain the mainstay for the treatment of moderate-to-severe cancer-associated pain. There is a new meta-analysis concerning opioid efficacy in this setting.
Buckle up; it's going to be a rough night.
Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.
